In Vivo Pharmacology | Animal Models of Human Diseases

In Vivo pharmacology is the study of the biological effects of a drug in a complex living organism and is used to observe the physiological effects of a drug. Testing drug candidates in animals is necessary step to understand the candidate behavior in the whole organism, starting from bioavailability and going through pharmacokinetics, organ exposure, efficacy in animal models of disease, and to a potential toxicity of either the compound itself or its metabolite(s).

GVK BIO has assembled a highly experienced team of scientists with strong background in drug discovery and in-depth knowledge in disease biology and expertise in In Vivo Pharmacology Models. Our scientific team has extensive experience helping patrons with the selection of appropriate animal models of disease, as well as collaborating to design new animal disease models to meet the specific needs of a patron or drug discovery program. Our scientists are well aligned with expectations from the industry regarding quality of scientific data and timeline.

Get in Touch With Our Scientific Team

I accept the terms and conditions of the website.

We offer In Vivo pharmacology services in accordance with customer’s-designed protocols supporting its discovery needs on flexible basis: from delivering standalone studies to taking over responsibility for planning and executing efficacy studies. GVK BIO offers early research and proof-of-principle pharmacology studies in relevant animal models of human diseases to assist your efficacy evaluations. We can customize our In Vivo pharmacology models to meet your unique objectives.

Our animal facility is accredited by AAALAC and OLAW for ethical treatment of animals. All the animal experiments at GVK BIO are conducted in accordance with IAEC approved protocols. All experimental procedures involving animals are carried out to the highest standards of animal welfare in state-of-the-art facilities. GVK BIO’s rodent facility is also certified by OHSAS for strictly following all recommended rules for health and safety of our employees.

We utilise a plethora of acute, mechanistic, pharmacodynamic models relevant to the target biology to assess target engagement and establish PK/ PD relationships. Our efficacy models are used to assess biological effects on pathophysiologies relevant to the disease of interest and are validated with appropriate standards of care and supported by rigorous statistical methods.

Why Partner with GVK BIO
Partnering Approach

Your research partner needs to understand your vision. That is why you place a strong emphasis on working closely with your contract R&D Company to develop appropriate or ‘fit-for-purpose’ study designs to meet your key objectives. With our emphasis on communication, GVK BIO can work with you in lock step on your path to drug discovery.

Holistic approach

Optimize the relationship between In Vivo pharmacology and toxicity. We bring together scientific experts from both disciplines on your project, to advance the best compound. This provides you with the best chances of long-term success throughout your drug development journey.

Quickness in Delivery

Our team takes a systematic approach to advance your drug candidate, to find and engage the disease target quickly and to modulate the target in the proper direction. Most importantly, we help ensure your compound works in a relevant and accepted disease model.

Quality Animals

Different rodent species used for the animal pharmacology studies are procured from internationally reputed vendors such as Taconic and Charles River who have established breeding facilities in Hyderabad.

Wide Customer Base

we have the experience in working on vast range of requirements from our client base that includes large, mid-size pharma and virtual companies across globe. We are sensitive to the requirements of each of these segments.

Speciality of Animal House

  • Our In Vivo Pharmacology Group believes in High Quality, Reproducible, Decision-Enabling Data with Continuous Scientific Engagement, Provided in a Timely, Cost-Effective Manner
  • AAALAC approved vivarium facility
  • Animal maintenance and experiments are as per the OSHAS and IAEC guidelines
  • Highest quality animals procured locally from internationally reputed vendors such as Taconic and Charles River
  • Physical examination and clinical symptoms of animals by veterinarian during the entire tenure of the study
  • Strong IP protection practices
  • Environmental Health & Safety is an essential part of our values system
  • Offer comprehensive list of more than 50 validated animal models in the therapeutic areas of oncology, cardiovascular, metabolic disease, fibrosis, inflammation and pain
  • Bioanalytical and biomarker support for measuring PK-PD correlations
  • FTE or FFS service models to provide best value to client

Infrastructure & Expertise

  • AAALAC accredited and OHSAS certified animal facility
  • 2 Veterinarians, 14 scientists including PhDs with collective 50 years of disease biology experience
  • Each therapeutic area is headed by an experienced PhD disease biologist
  • Scientists with broad drug discovery experience from target identification/validation to IND submission
  • Extensive in-house experience of validating rodent models and providing screening support for clients
  • Compounds screened and characterised by our team have progressed to IND studies
  • Efficacy models are supported by appropriate PD biomarker & histopathology analysis
  • Dedicated veterinarians and pathologists to support efficacy and toxicity studies

Our In Vivo Pharmacology capabilities include

  • Testing numerous medicinal entities, including small molecules and antibodies
  • Inducing disease by multiple techniques – chemical, surgical and diet
  • Dosing by commonly used administration routes – p.o,, i.v., s.c., i.p.
  • Performing necropsies and histopathology, IHC, gene expression and blood chemistry
  • Executing standard or custom tailored protocols

In Vivo Pharmacology for CVMD

GVK BIO’s In Vivo pharmacology team has a strong expertise in supporting drug discovery in the area of cardiovascular and metabolic diseases.

GVK BIO offers a range of developed and well characterised target engagement/efficacy models of Type 1 and 2 Diabetes, obesity, liver renal diseases, with a particular focus on NASH and hepatic fibrosis respectively. In addition our team routinely develop bespoke models to fit our collaborator’s specific project needs.

In Vivo Pharmacology for Pain & Inflammation

GVK BIO’s scientists have in-depth knowledge and expertise in a wide range of rodent models in pain and inflammation. We deal with inflammation triggered diseases such as Lung Fibrosis. We offer a range of inflammatory pain models from acute inflammatory pain to chronic pain associated with arthritic conditions. Pain can be caused by a variety of situations including inflammatory diseases such inflammatory pain and neuropathic pain. The study analysis is conducted in a blinded method to avoid any bias.

In Vivo Pharmacology Oncology

GVK BIO has a long-standing expertise in oncology, including contributing to multiple clinical candidates and one marketed drug. GVK BIO offers a range of mouse, syngeneic and orthotopic xenograft models, coupled with the possibility of a broad range of efficacy and biomarker read-outs.

vivo-pharma

© 2018 | GVK Biosciences Private Limited, All Rights Reserved | Terms & Conditions

Log in with your credentials

Forgot your details?